Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/16814257
Conclusion of this study
This study did not find overall evidence of efficacy for adjunctive treatment with EPA 6 g/day in outpatients with bipolar depression or rapid cycling bipolar disorder.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study